Real-world Radicava use in ALS tied to unexpected side effects: Data
The real-world use of Radicava (edaravone), an infusion treatment approved for amyotrophic lateral sclerosis (ALS), may cause serious…
Articles by Margarida Maia, PhD
Groups ask lawmakers to preserve National ALS Registry funding
ALS groups are asking lawmakers to preserve federal funding for the National ALS Registry and National ALS Biorepository, the first…
Brain-computer interface to restore speech named award winner
A neurosurgeon and his team from the University of California (UC) Davis Health have won The Herbert Pardes Clinical Research…
RNS60 safe, well tolerated in EAP for advanced ALS
RNS60 was well tolerated when inhaled twice daily at home as part of an expanded access program (EAP), and it…
AAN 2025: PrimeC reduces miRNAs linked to ALS progression
Neurosense Therapeutics’ oral therapy PrimeC significantly reduces blood levels of miRNAs — molecules involved in regulating gene activity — associated…
Silence ALS treats 9 patients’ rare ALS caused by CHCHD10 mutations
Nine patients with an ultra-rare form of amyotrophic lateral sclerosis (ALS) caused by mutations in the CHCHD10 gene were…
Health Canada set to consider giving early approval to PrimeC for ALS
Health Canada has invited Neurosense Therapeutics to discuss the potential for giving conditional approval to PrimeC in treating…
QRL-101 reduces motor neuron excitability in healthy volunteers
An experimental oral small molecule being developed by Quralis for amyotrophic lateral sclerosis (ALS) reduced motor neuron excitability…
Cognixion seeks ALS patients for clinical trial of BCI headset
Cognixion is recruiting adults with amyotrophic lateral sclerosis (ALS) for a clinical trial testing ONE Axon-R, a wearable headset…
39 Canadians in ALS community presented with Coronation Medals
The ALS Society of Canada (ALS Canada) has named 39 Canadians to be presented the King Charles III Coronation…